On motion of Nathalie Sinclair-Desgagné, it was agreed, — That the committee proceed to resuming consideration of the motion of Nathalie Sinclair-Desgagné in regard to contracts by Public Services and Procurement Canada for the supply of COVID-19 vaccines, and the amendment of Anthony Housefather.

The committee resumed consideration of the motion of Nathalie Sinclair-Desgagné moved on Monday, February 13, 2023, which read as follows:

That, pursuant to Standing Order 108(3)(g), the committee undertake a study of the contracts between Public Services and Procurement Canada with Moderna, Sanofi, Pfizer, Medicago, AstraZeneca, Johnson & Johnson and Novavax for the supply of COVID-19 vaccines (Auditor General's Report 9 and 10);

That, pursuant to Standing Order 108(1), the committee order Public Services and Procurement Canada to produce a copy of each of the said contracts by forwarding them to the clerk of the committee within 15 days of the adoption of this motion, provided that they are free of any redactions;

That, when these documents are received by the clerk:

(a) They be available at the clerk's office for viewing by committee members only, for one day to be designated by the committee no later than 15 days following the receipt of the contracts, under the supervision of the clerk and that no personal mobile or electronic devices be permitted in the room that day;

(b) Representatives of Public Services and Procurement Canada be invited to appear for a two hour in camera meeting and that during the meeting, only committee members and support staff required for the meeting be permitted to attend and that no personal mobile or electronic devices be permitted in the room during the meeting; that, during the meeting, numbered paper copies of the documents be given to committee members who are present in person by the clerk at the beginning of the said meeting and that these copies be returned to the clerk at the end of the meeting and that the clerk be instructed to destroy the said copies.

and of the amendment of Anthony Housefather moved on Thursday, February 16, 2023, which read as follows:

That the motion be amendment by deleting all the words after “(Auditor General’s Report 9 and 10);” with the following:

That the committee clerk write to each of the suppliers signaling the willingness of committee members to sign non-disclosure agreements in order to review unredacted copies of the contracts, and, should the suppliers decline, the suppliers would be required to provide a written explanation to the committee as to the nature of the information being withheld and the reasons for withholding it from Members of Parliament; and, if after 30 days, the committee has not received a response, or the committee is not satisfied with the responses, members sign non-disclosure agreements in order to review unredacted copies of the contracts. In either case, these contracts would be provided by Public Services and Procurement Canada in a predetermined Government of Canada secure location and Public Services and Procurement Canada officials be made available to respond to committee members questions regarding the documents. Documents would be provided to Members of Parliament only and on the condition that the documents not leave the location and all of the rules of the secure location are followed.

Furthermore, the committee requests that Public Services and Procurement Canada officials be available for future in camera meetings to discuss the topic.

Debate arose thereon.

By unanimous consent, the amendment of Anthony Housefather was withdrawn.

It was agreed, — That the committee invite, at the earliest opportunity, the representatives of Moderna, Sanofi, Pfizer, Medicago, AstraZeneca, Johnson & Johnson and Novavax, and the Law Clerk and Parliamentary Counsel, in view of its study on Report 9, COVID-19 Vaccines, of the 2022 Reports 9 and 10 of the Auditor General of Canada.

It was agreed, — That the proposed budget in the amount of $1,100, for the study of Report 4, Systemic Barriers—Correctional Service Canada, of the 2022 Reports 1 to 4 of the Auditor General of Canada, be adopted.

It was agreed, — That the proposed budget in the amount of $1,625, for the study of the Report 7 – Cybersecurity of Personal Information in the Cloud of the 2022 Reports 5 to 8 of the Auditor General of Canada, be adopted.

It was agreed, — That the proposed budget in the amount of $1,100, for the study of Report 9, COVID-19 Vaccines, of the 2022 Reports 9 and 10 of the Auditor General of Canada, be adopted.

It was agreed, — That the proposed budget in the amount of $2,375, for the study of Report 10, Specific COVID-19 Benefits, of the 2022 Reports 9 and 10 of the Auditor General of Canada, be adopted.